Sangamo Therapeutics, Inc. (SGMO)
NASDAQ: SGMO · Real-Time Price · USD
0.496
-0.034 (-6.45%)
At close: Dec 5, 2025, 4:00 PM EST
0.497
+0.002 (0.30%)
After-hours: Dec 5, 2025, 7:59 PM EST

Sangamo Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2019 - 2015
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019 - 2015
Market Capitalization
167213965151,0932,207
Upgrade
Market Cap Growth
-57.90%120.88%-81.28%-52.90%-50.50%127.45%
Upgrade
Enterprise Value
163201-12046141,554
Upgrade
Last Close Price
0.501.020.543.147.5015.61
Upgrade
PS Ratio
3.743.680.554.629.8718.68
Upgrade
PB Ratio
25.589.351.161.752.914.44
Upgrade
P/TBV Ratio
26.739.351.162.493.885.56
Upgrade
P/FCF Ratio
-----14.23
Upgrade
P/OCF Ratio
-----12.99
Upgrade
EV/Sales Ratio
4.953.48-1.835.5413.15
Upgrade
EV/FCF Ratio
-----10.01
Upgrade
Debt / Equity Ratio
4.071.340.460.150.130.09
Upgrade
Debt / FCF Ratio
-----0.27
Upgrade
Asset Turnover
0.330.430.480.170.130.15
Upgrade
Quick Ratio
0.691.021.782.532.994.51
Upgrade
Current Ratio
0.881.131.982.693.124.60
Upgrade
Return on Equity (ROE)
-480.02%-185.39%-136.47%-57.37%-40.86%-26.05%
Upgrade
Return on Assets (ROA)
-68.11%-46.05%-19.63%-19.59%-13.80%-10.27%
Upgrade
Return on Capital (ROIC)
-138.19%-70.52%-31.12%-33.04%-23.80%-15.93%
Upgrade
Return on Capital Employed (ROCE)
-282.80%-176.20%-97.20%-44.60%-30.90%-16.30%
Upgrade
Earnings Yield
-65.27%-46.02%-267.59%-37.37%-16.32%-5.48%
Upgrade
FCF Yield
-45.78%-31.67%-255.31%-47.38%-23.48%7.03%
Upgrade
Buyback Yield / Dilution
-28.22%-15.62%-13.02%-6.76%-7.53%-19.92%
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.